These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8356179

  • 1. [Rat's nigrostriatal dopamine system under the influence of insulin in alloxan diabetes].
    Majewski K, Braszko J, Wiśniewski K.
    Psychiatr Pol; 1993; 27(3):325-35. PubMed ID: 8356179
    [No Abstract] [Full Text] [Related]

  • 2. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies.
    Liou HH, Chen RC, Tsai YF, Chen WP, Chang YC, Tsai MC.
    Toxicol Appl Pharmacol; 1996 Mar; 137(1):34-41. PubMed ID: 8607139
    [Abstract] [Full Text] [Related]

  • 3. Effect of intracisternally administered adenosine and inosine on apomorphine- and amphetamine-induced stereotyped behaviour in rats.
    Singh J.
    Indian J Physiol Pharmacol; 1990 Jan; 34(1):45-7. PubMed ID: 2361724
    [No Abstract] [Full Text] [Related]

  • 4. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N, Vidal L, Alvarez P, Blanco L, Torres A, Rodríguez A, Macías R.
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [Abstract] [Full Text] [Related]

  • 5. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 6. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 7. [The effect of ethanol on the motor activity of rats and on the content of GABA and dopamine and its metabolites in the nigrostriatal system].
    Karpova IV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992 Sep; 42(5):1027-30. PubMed ID: 1336265
    [No Abstract] [Full Text] [Related]

  • 8. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 9. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release.
    Guyon A, Skrzydelski D, De Giry I, Rovère C, Conductier G, Trocello JM, Daugé V, Kitabgi P, Rostène W, Nahon JL, Mélik Parsadaniantz S.
    Neuroscience; 2009 Sep 15; 162(4):1072-80. PubMed ID: 19477239
    [Abstract] [Full Text] [Related]

  • 10. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
    Dusonchet J, Bensadoun JC, Schneider BL, Aebischer P.
    Neurobiol Dis; 2009 Jul 15; 35(1):32-41. PubMed ID: 19348945
    [Abstract] [Full Text] [Related]

  • 11. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats.
    Chandra G, Gangopadhyay PK, Senthil Kumar KS, Mohanakumar KP.
    Brain Res; 2006 Feb 23; 1075(1):81-92. PubMed ID: 16487496
    [Abstract] [Full Text] [Related]

  • 12. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
    Nowak P, Kostrzewa RM, Kwieciński A, Bortel A, Labus Ł, Brus R.
    J Physiol Pharmacol; 2005 Jun 23; 56(2):325-33. PubMed ID: 15985712
    [Abstract] [Full Text] [Related]

  • 13. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 23; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.
    Liou HH, Chen RC, Chen TH, Tsai YF, Tsai MC.
    Toxicol Appl Pharmacol; 2001 Apr 01; 172(1):37-43. PubMed ID: 11264021
    [Abstract] [Full Text] [Related]

  • 15. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
    Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M.
    Neurosci Res; 2005 Mar 01; 51(3):299-308. PubMed ID: 15710494
    [Abstract] [Full Text] [Related]

  • 16. Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract.
    Pum ME, Schäble S, Harooni HE, Topic B, De Souza Silva MA, Li JS, Huston JP, Mattern C.
    Neuroscience; 2009 Aug 04; 162(1):174-83. PubMed ID: 19401223
    [Abstract] [Full Text] [Related]

  • 17. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
    Gouhier C, Chalon S, Aubert-Pouessel A, Venier-Julienne MC, Jollivet C, Benoit JP, Guilloteau D.
    Synapse; 2002 Jun 01; 44(3):124-31. PubMed ID: 11954043
    [Abstract] [Full Text] [Related]

  • 18. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M, Gonzalez S, Morales I, Sabate M, Gonzalez-Hernandez T, Gonzalez-Mora JL.
    Eur J Neurosci; 2007 May 01; 25(9):2755-65. PubMed ID: 17561841
    [Abstract] [Full Text] [Related]

  • 19. [Intracerebroventricular administration of cholecystokinin inhibits the dopamine- and serotoninergic systems of the brain].
    Vasar EE, Otter MIa, Riago LK.
    Fiziol Zh SSSR Im I M Sechenova; 1982 Sep 01; 68(9):1218-22. PubMed ID: 7173435
    [Abstract] [Full Text] [Related]

  • 20. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system.
    Skrzydelski D, Guyon A, Daugé V, Rovère C, Apartis E, Kitabgi P, Nahon JL, Rostène W, Parsadaniantz SM.
    J Neurochem; 2007 Aug 01; 102(4):1175-83. PubMed ID: 17509088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.